BioSpace News Archive

Cancer Biologics Market Size, Share, Growth, Analysis and Trends Report by 2033

According to latest report, the global cancer biologics market size was USD 103.98 billion in 2023, calculated at USD 111.40 billion in 2024, and is expected to reach around USD 207.24 billion by 2033, expanding at a CAGR of 7.14% from 2024 to 2033.

July 1, 2024

·

6 min read

Press Releases

Paradromics accepted to FDA regulatory accelerator program and announces new patient registry

July 1, 2024

·

3 min read

Press Releases

U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes

July 1, 2024

·

4 min read

Press Releases

Reflow Medical Enrolls First Patients in Pilot Study of Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute)

July 1, 2024

·

2 min read

Press Releases

Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)

Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy

July 1, 2024

·

4 min read

Press Releases

N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials

July 1, 2024

·

2 min read

Press Releases

Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment

July 1, 2024

·